Title:
An open label, multicentre, randomized, single-dose, parallel, two-treatment, bioequivalence study of Ferric Carboxymaltose Injection 750 mg/15mL (50 mg/mL) of RK Pharma Inc. with INJECTAFER® (Ferric Carboxymaltose Injection 750 mg/15 mL [50mg/mL]) of American Regent, Inc. Shirley, NY 11967, following a single intravenous dose of 750mg in adult human patients with iron deficiency anaemia.